Committed to developing or modifying existing drugs for a range of conditions within 'isolated biological environments', such as the eye, spinal cord or joint. This allows a drug to reach commercialization faster and more efficiently since non-systemic distribution has the potential for fewer risks and safety issues. (BIOTECanada)(LSBC)